Meet our project team

FT3 Board

The Board leads the program, defining the long and medium-term objectives while respecting internal FT3 principles and rules. It represents the interests of members. The role of the FT3 Board member is voluntary and is not compensated for.

Find out more about the FT3 Governance structure.

Andrea Ferris

President and CEO, LUNGevity Foundation

Begoña Nafría Escalera

Patient Engagement in Research Coordinator, SJD Research Foundation

Dr. Ben Westphalen

Comprehensive Cancer Center Munich

Dr. Durhane Wong-Rieger

President, CORD

Sandra Blum

Principal Director, Global Patient Partnership, Roche

Ivica Belina

President, Koalicija udruga u zdravstvu (KUZ)

Judith Taylor

Co-Director and Secretary, Thyroid Cancer Alliance

Dr. Pooja Merchant

Head Patient Partnerships and Engagement Oncology, Bayer

Ralph Riley

Global Co-Diagnostics Market Access Leader, Janssen

Tanya Knott

Director, Sarah Jennifer Knott Foundation

Barry Stein

President & CEO
Colorectal Cancer Canada

Denis Costello

Executive Director
CML Advocates Network

Lee-Anne Zinetti
Senior

Director of Global Precision Diagnostics
Novartis

Susan McClure

Patient Representative

Nicole Sheahan

President, Global Colon Cancer Association

Dr. Charles Alessi

Independent Expert

James Creeden

Independent Expert

Executive Team

The Executive Committee is responsible for the supervision of the Executive Director and the day-to-day strategic management of the program. With their knowledge and know-how, the Executive Committee provides valuable support for the Executive Director in day-to-day operations and decision-making. The role of the Executive Committee member is voluntary and is not compensated for.